IndraLab

Statements


ATXN3 activates IGFALS. 2 / 2
| 2

reach
"Several genome-wide association studies in ALS patients have identified mutations in ATXN3 that increase the risk of developing ALS."

reach
"Contrary to expectations, alleles 40/42/44 were observed only among controls, with a frequency of 2.7%, indicating that ATXN3 expansions are not increasing ALS risk."